Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 17 04:00PM ET
29.78
Dollar change
-0.06
Percentage change
-0.20
%
IndexRUT P/E19.59 EPS (ttm)1.52 Insider Own0.79% Shs Outstand174.58M Perf Week-1.13%
Market Cap5.18B Forward P/E21.79 EPS next Y1.37 Insider Trans2.46% Shs Float172.44M Perf Month-3.62%
Income272.67M PEG1.96 EPS next Q0.28 Inst Own97.54% Short Float2.85% Perf Quarter-12.23%
Sales4.43B P/S1.17 EPS this Y-19.96% Inst Trans3.09% Short Ratio3.62 Perf Half Y1.12%
Book/sh8.22 P/B3.62 EPS next Y15.39% ROA8.55% Short Interest4.92M Perf Year5.64%
Cash/sh1.26 P/C23.58 EPS next 5Y10.00% ROE19.62% 52W Range26.17 - 35.74 Perf YTD-11.61%
Dividend Est.- P/FCF30.30 EPS past 5Y- ROI10.59% 52W High-16.68% Beta1.31
Dividend TTM- Quick Ratio1.39 Sales past 5Y17.51% Gross Margin21.01% 52W Low13.79% ATR (14)0.76
Dividend Ex-Date- Current Ratio1.77 EPS Y/Y TTM74.47% Oper. Margin7.15% RSI (14)41.08 Volatility1.76% 2.85%
Employees5809 Debt/Eq0.82 Sales Y/Y TTM9.59% Profit Margin6.15% Recom1.11 Target Price39.45
Option/ShortYes / Yes LT Debt/Eq0.80 EPS Q/Q18.83% Payout0.00% Rel Volume0.60 Prev Close29.84
Sales Surprise4.03% EPS Surprise15.15% Sales Q/Q12.82% EarningsApr 23 BMO Avg Volume1.36M Price29.78
SMA20-1.01% SMA50-4.66% SMA200-6.83% Trades Volume813,734 Change-0.20%
Date Action Analyst Rating Change Price Target Change
Feb-27-23Resumed Jefferies Buy $38
Jul-19-21Upgrade Goldman Neutral → Buy $20 → $25
Jan-22-21Initiated Deutsche Bank Buy $22
Jan-11-21Initiated JP Morgan Overweight $21
Dec-15-20Initiated Goldman Neutral $18
Jun-24-20Initiated BofA/Merrill Buy $18
May-16-24 05:23PM
04:05PM
Apr-29-24 04:05PM
Apr-26-24 12:00PM
09:40AM
11:27AM Loading…
Apr-25-24 11:27AM
Apr-24-24 03:49AM
03:03AM
Apr-23-24 11:54AM
08:33AM
08:19AM
08:15AM
07:15AM
07:00AM
Apr-22-24 12:10PM
10:00AM Loading…
Apr-16-24 10:00AM
Apr-04-24 04:05PM
Mar-26-24 05:25PM
Mar-14-24 07:14PM
05:04PM
04:58PM
04:25PM
Mar-07-24 10:07AM
Feb-23-24 12:34PM
Feb-22-24 11:53PM
08:20AM
07:31AM
07:24AM
07:00AM
Feb-02-24 06:10AM
04:05PM Loading…
Jan-22-24 04:05PM
Jan-08-24 07:00AM
Dec-19-23 05:14AM
Dec-11-23 04:05PM
Dec-06-23 04:11PM
Nov-07-23 04:05PM
Oct-26-23 09:35AM
Oct-25-23 10:27PM
07:05PM
09:56AM
08:15AM
07:08AM
07:00AM
Oct-20-23 11:47AM
Oct-18-23 12:04PM
Oct-16-23 02:53PM
Oct-02-23 05:56AM
Sep-29-23 03:59PM
08:19AM
Sep-28-23 08:26PM
Sep-27-23 09:24PM
04:05PM
Sep-15-23 09:18AM
Sep-12-23 08:32AM
Sep-08-23 06:23PM
Sep-05-23 07:54AM
Sep-01-23 11:19AM
Aug-31-23 05:00PM
11:40AM
03:34AM
Aug-28-23 09:59AM
Aug-18-23 07:39AM
Aug-14-23 07:03PM
Aug-11-23 09:39AM
Aug-10-23 12:20PM
10:12AM
Aug-03-23 08:06AM
Aug-02-23 07:53AM
07:37AM
Jul-28-23 12:00PM
Jul-27-23 08:25AM
07:20AM
07:00AM
Jul-25-23 05:36AM
Jul-19-23 11:40AM
Jul-06-23 11:22AM
08:00AM
Jun-30-23 01:04PM
Jun-28-23 09:21AM
Jun-27-23 08:18AM
Jun-26-23 01:39PM
09:04AM
08:57AM
08:44AM
Jun-21-23 08:00PM
Jun-11-23 03:45AM
Jun-06-23 01:14PM
08:55AM
Jun-05-23 11:40AM
08:31AM
08:25AM
08:13AM
May-23-23 04:05PM
11:53AM
May-18-23 04:05PM
May-05-23 04:05PM
May-04-23 12:29PM
May-03-23 07:35PM
06:27PM
04:53PM
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bavaro MichaelChief Human Resources OfficerFeb 28 '24Sale31.731,98462,94443,428Mar 01 04:28 PM
KRAEMER HARRY M JANSEN JRDirectorFeb 26 '24Buy31.5535,0001,104,352269,528Feb 28 04:41 PM
RADEMACHER JOHN CHARLESChief Executive OfficerFeb 21 '24Option Exercise0.0011,0870705,876Feb 23 06:21 PM
SHAPIRO MICHAEL H.Chief Financial OfficerFeb 17 '24Option Exercise0.003,6520180,570Feb 21 09:55 PM
Bierbower Elizabeth DDirectorOct 30 '23Buy26.373,00079,11013,515Nov 01 05:09 PM
Pate R CarterDirectorAug 17 '23Buy34.321,46550,279106,112Aug 21 05:08 PM
Smyser CollinGC & Corporate SecretaryAug 14 '23Buy34.692,50086,7252,500Aug 15 05:24 PM
KRAEMER HARRY M JANSEN JRDirectorAug 11 '23Buy34.6355,0001,904,518234,528Aug 15 05:26 PM
Last Close
May 17 04:00PM ET
148.67
Dollar change
+1.11
Percentage change
0.75
%
IndexS&P 500 P/E64.08 EPS (ttm)2.32 Insider Own1.23% Shs Outstand135.77M Perf Week0.81%
Market Cap20.10B Forward P/E16.16 EPS next Y9.20 Insider Trans-1.07% Shs Float133.54M Perf Month20.13%
Income321.00M PEG6.16 EPS next Q2.19 Inst Own76.33% Short Float1.12% Perf Quarter20.06%
Sales15.71B P/S1.28 EPS this Y17.70% Inst Trans-1.74% Short Ratio1.56 Perf Half Y41.64%
Book/sh31.52 P/B4.72 EPS next Y7.08% ROA2.47% Short Interest1.50M Perf Year89.27%
Cash/sh5.52 P/C26.91 EPS next 5Y10.40% ROE7.41% 52W Range76.58 - 148.73 Perf YTD37.35%
Dividend Est.1.54 (1.04%) P/FCF17.62 EPS past 5Y-17.61% ROI3.42% 52W High-0.04% Beta0.69
Dividend TTM1.48 (1.00%) Quick Ratio1.24 Sales past 5Y8.68% Gross Margin15.19% 52W Low94.14% ATR (14)2.11
Dividend Ex-DateJun 14, 2024 Current Ratio1.35 EPS Y/Y TTM-51.92% Oper. Margin9.24% RSI (14)82.07 Volatility1.10% 1.57%
Employees47000 Debt/Eq1.22 Sales Y/Y TTM7.62% Profit Margin2.04% Recom1.65 Target Price158.16
Option/ShortYes / Yes LT Debt/Eq1.21 EPS Q/Q76.59% Payout101.25% Rel Volume0.71 Prev Close147.56
Sales Surprise4.10% EPS Surprise34.80% Sales Q/Q7.46% EarningsApr 30 BMO Avg Volume955.88K Price148.67
SMA206.96% SMA5012.38% SMA20033.53% Trades Volume674,452 Change0.75%
Date Action Analyst Rating Change Price Target Change
Jan-05-24Upgrade Barclays Equal Weight → Overweight
Nov-17-23Upgrade Argus Hold → Buy
May-25-23Upgrade Wells Fargo Equal Weight → Overweight $87 → $102
Mar-27-23Downgrade Jefferies Buy → Hold $120 → $95
Dec-08-22Initiated Citigroup Buy $130
Aug-30-22Initiated RBC Capital Mkts Sector Perform $106
Jun-07-22Downgrade Barclays Overweight → Equal Weight $105
Mar-24-22Downgrade Wells Fargo Overweight → Equal Weight $97 → $113
Mar-18-22Resumed Stifel Buy $126
Aug-20-21Downgrade Argus Buy → Hold
May-17-24 09:15AM
May-16-24 09:00AM
May-14-24 09:45AM
08:00AM
May-10-24 06:00AM
12:00PM Loading…
May-08-24 12:00PM
May-07-24 11:18AM
09:30AM
09:00AM
08:00AM
May-06-24 12:20PM
06:28AM
May-03-24 04:23PM
09:35AM
01:11AM
02:19PM Loading…
May-01-24 02:19PM
11:40AM
11:27AM
11:19AM
11:19AM
10:59AM
10:57AM
10:57AM
10:27AM
09:15AM
08:00AM
07:24AM
03:03AM
Apr-30-24 04:41PM
10:55AM
10:40AM Loading…
10:40AM
09:30AM
09:28AM
09:26AM
07:32AM
06:41AM
06:04AM
06:00AM
Apr-26-24 05:50PM
04:15PM
Apr-24-24 06:00PM
01:27PM
09:00AM
Apr-23-24 10:00AM
Apr-19-24 09:30AM
Apr-18-24 06:00PM
Apr-17-24 09:40AM
Apr-15-24 08:00AM
Apr-12-24 06:00PM
02:48PM
Apr-11-24 12:10PM
09:45AM
09:40AM
Apr-09-24 08:00AM
Apr-08-24 06:15PM
Apr-05-24 11:48AM
Apr-02-24 08:00AM
Mar-29-24 08:00AM
Mar-28-24 08:00AM
Mar-26-24 09:45AM
Mar-25-24 10:15AM
Mar-22-24 09:50AM
Mar-21-24 10:41AM
Mar-20-24 08:00AM
08:00AM
Mar-18-24 01:55PM
Mar-15-24 10:10AM
Mar-14-24 11:30AM
Mar-11-24 08:32AM
Mar-07-24 04:00PM
Mar-06-24 09:50AM
08:00AM
Mar-05-24 12:00PM
08:00AM
Mar-04-24 08:00AM
Feb-28-24 09:40AM
Feb-23-24 02:05PM
Feb-22-24 11:29PM
Feb-21-24 02:55PM
Feb-16-24 02:31PM
Feb-15-24 08:00AM
Feb-14-24 11:52PM
02:22PM
09:09AM
12:28AM
Feb-13-24 09:45AM
09:30AM
07:20AM
07:10AM
06:34AM
06:17AM
06:17AM
06:00AM
Feb-12-24 09:40AM
Feb-08-24 04:15PM
04:00PM
09:31AM
09:15AM
08:00AM
Feb-06-24 10:00AM
Leidos Holdings, Inc. engages in providing services and solutions in the defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment provides services, solutions, and products focusing on digital modernization, mission systems and integration, command, control, computers, communications, intelligence, surveillance and reconnaissance technologies and services, maritime solutions, transformative software, analytics, intelligence analysis, mission support and logistics services, weapons systems and space systems and solutions. The Civil segment focuses on modernizing infrastructure, systems, and security. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fasano Gerard AChief Growth OfficerMay 02 '24Option Exercise102.8922,5402,319,180110,502May 03 04:21 PM
Kovarik Robert C JRDirectorMay 02 '24Option Exercise70.643,879274,01311,481May 03 04:12 PM
SHAPARD ROBERT SDirectorMay 02 '24Option Exercise52.704,788252,32855,000May 03 04:09 PM
STALNECKER SUSAN MDirectorMay 02 '24Option Exercise52.704,788252,32819,536May 03 04:15 PM
KRAEMER HARRY M JANSEN JRDirectorMay 02 '24Option Exercise52.704,788252,32889,065May 03 04:18 PM
STALNECKER SUSAN MDirectorMay 02 '24Sale141.973,014427,90914,748May 03 04:15 PM
Kovarik Robert C JRDirectorMay 02 '24Sale142.211,952277,5927,602May 03 04:12 PM
Fubini David GDirectorMar 13 '24Sale127.897,8741,006,96914,696Mar 14 06:18 PM
Dahlberg Gregory RDirectorFeb 26 '24Option Exercise52.704,788252,32820,195Feb 27 04:52 PM
Hull Stephen EdwardSector PresidentFeb 26 '24Option Exercise53.543,423183,26727,583Feb 27 04:47 PM
Geer Noel BDirectorFeb 22 '24Option Exercise52.704,788252,32829,925Feb 23 05:18 PM
May Gary StephenDirectorFeb 21 '24Option Exercise52.704,788252,32816,140Feb 22 04:59 PM
May Gary StephenDirectorFeb 21 '24Sale124.492,745341,72111,352Feb 22 04:59 PM
Porter Elizabeth ASector PresidentFeb 16 '24Option Exercise53.543,268174,96938,493Feb 20 05:33 PM
Fubini David GDirectorFeb 15 '24Option Exercise103.973,892404,66225,902Feb 16 04:15 PM
HOWE JERALD S JREVP, General CounselFeb 15 '24Option Exercise56.476,862387,49732,263Feb 16 04:13 PM
Cage Christopher RChief Financial OfficerFeb 15 '24Option Exercise53.542,774148,52037,729Feb 16 04:11 PM
MOHAPATRA SURYA NDirectorNov 22 '23Option Exercise52.704,788252,32823,877Nov 24 04:33 PM
MOHAPATRA SURYA NDirectorNov 22 '23Sale105.832,401254,10219,089Nov 24 04:33 PM
JOHN MIRIAM EDirectorNov 16 '23Sale105.207,255763,20320,436Nov 17 04:33 PM
Fasano Gerard AGroup PresidentNov 13 '23Option Exercise71.5217,6501,262,41596,376Nov 15 04:29 PM
Fubini David GDirectorNov 06 '23Option Exercise62.2812,203760,00529,324Nov 07 04:39 PM
Geer Noel BDirectorNov 06 '23Sale103.232,106217,40329,894Nov 08 05:04 PM
Moos James RobertGroup PresidentNov 03 '23Option Exercise53.542,134114,25431,082Nov 06 04:31 PM
Moos James RobertGroup PresidentNov 03 '23Sale103.6656458,46428,948Nov 06 04:31 PM
Stevens Roy EGroup PresidentNov 02 '23Option Exercise53.543,592192,31642,645Nov 03 04:27 PM
Stevens Roy EGroup PresidentNov 02 '23Sale103.2092995,87339,053Nov 03 04:27 PM
JOHN MIRIAM EDirectorAug 10 '23Option Exercise39.705,193206,16229,805Aug 14 04:41 PM
SHAPARD ROBERT SDirectorAug 04 '23Option Exercise39.705,193206,16252,308Aug 04 04:44 PM
KRAEMER HARRY M JANSEN JRDirectorAug 04 '23Option Exercise39.705,193206,16289,470Aug 07 04:38 PM
KRAEMER HARRY M JANSEN JRDirectorAug 04 '23Sale96.953,098300,36084,277Aug 07 04:38 PM
Bell Thomas ArthurCEOMay 22 '23Buy78.816,300496,5026,300May 22 04:42 PM